A
restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial
Belavić, M., Sotošek Tokmadžić, V., Brozović Krijan, A., Kvaternik, I., Matijaš, K., Strikić, N. & Žunić, J. (2018). A
restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial. Therapeutics and Clinical Risk Management, 14., 741-745. doi: 10.2147/TCRM.S160778
Belavić, Matija, et al. "A
restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial." Therapeutics and Clinical Risk Management, vol. 14, 2018, pp. 741-745. https://doi.org/10.2147/TCRM.S160778
Belavić, Matija, Vlatka Sotošek Tokmadžić, Antonija Brozović Krijan, Ines Kvaternik, Kristina Matijaš, Nedjeljko Strikić and Josip Žunić. "A
restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial." Therapeutics and Clinical Risk Management 14 (2018): 741-745. https://doi.org/10.2147/TCRM.S160778
Belavić, M., et al. (2018) 'A
restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial', Therapeutics and Clinical Risk Management, 14, pp. 741-745. doi: 10.2147/TCRM.S160778
Belavić M, Sotošek Tokmadžić V, Brozović Krijan A, Kvaternik I, Matijaš K, Strikić N, and sur.. A
restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial. Therapeutics and Clinical Risk Management [Internet]. 2018 April [cited 2024 August 20];14:741-745. doi: 10.2147/TCRM.S160778
M. Belavić, et al., "A
restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial", Therapeutics and Clinical Risk Management, vol. 14, pp. 741-745, April 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:441313. [Accessed: 20 August 2024]